Correction: CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers
Prahlad V. Raninga, Bijun Zeng, Davide Moi, Ethan Trethowan, Federica Saletta, Pooja Venkat, Chelsea Mayoh, Rochelle C. J. D’Souza, Bryan W. Day, Tyler Shai-Hee, Orazio Vittorio, Roberta Mazzieri, Riccardo Dolcetti, Kum Kum Khanna
Abstract
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsImmune Cell Function and Interaction · Immune cells in cancer · Cancer Immunotherapy and Biomarkers
Correction to: Oncogene 10.1038/s41388-024-03259-y, published online 21 December 2024
The article ‘CBL0137 and NKG2A blockade: a novel immuno-oncology combination therapy for Myc-overexpressing triple-negative breast cancers’, written by Prahlad V. Raninga, Bijun Zeng, Davide Moi, Ethan Trethowan, Federica Saletta, Pooja Venkat, Chelsea Mayoh, Rochelle C. J. D’Souza, Bryan W. Day, Tyler Shai-Hee, Orazio Vittorio5, Roberta Mazzieri, Riccardo Dolcetti and Kum Kum Khanna, was originally published under exclusive license to The Author(s), under exclusive licence to Springer Nature Limited 2024. As a result of the subsequent decision to publish the article under the open access model, the article’s copyright notice was changed on 17. February 2025 to ©The Author(s) 2025 and the article is now distributed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made.
The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder.
To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Open Access funding enabled and organized by CAUL and its Member Institutions.